BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

766 related articles for article (PubMed ID: 31226956)

  • 1. Artificial neural network models to predict nodal status in clinically node-negative breast cancer.
    Dihge L; Ohlsson M; Edén P; Bendahl PO; Rydén L
    BMC Cancer; 2019 Jun; 19(1):610. PubMed ID: 31226956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective validation study of an artificial neural network-based preoperative decision-support tool for noninvasive lymph node staging (NILS) in women with primary breast cancer (ISRCTN14341750).
    Skarping I; Ellbrant J; Dihge L; Ohlsson M; Huss L; Bendahl PO; Rydén L
    BMC Cancer; 2024 Jan; 24(1):86. PubMed ID: 38229058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomograms for preoperative prediction of axillary nodal status in breast cancer.
    Dihge L; Bendahl PO; Rydén L
    Br J Surg; 2017 Oct; 104(11):1494-1505. PubMed ID: 28718896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can a machine-learning model improve the prediction of nodal stage after a positive sentinel lymph node biopsy in breast cancer?
    Madekivi V; Boström P; Karlsson A; Aaltonen R; Salminen E
    Acta Oncol; 2020 Jun; 59(6):689-695. PubMed ID: 32148141
    [No Abstract]   [Full Text] [Related]  

  • 5. Predictors for extensive nodal involvement in breast cancer patients with axillary lymph node metastases.
    Verheuvel NC; Ooms HW; Tjan-Heijnen VC; Roumen RM; Voogd AC
    Breast; 2016 Jun; 27():175-81. PubMed ID: 27123958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Establishment of artificial neural network model for predicting lymph node metastasis in patients with stage Ⅱ-Ⅲ gastric cancer].
    Xue Z; Lu J; Lin J; Huang CM; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Zheng CH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Apr; 25(4):327-335. PubMed ID: 35461201
    [No Abstract]   [Full Text] [Related]  

  • 7. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
    Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
    Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.
    Choi SH; Barsky SH; Chang HR
    Breast J; 2003; 9(3):153-62. PubMed ID: 12752622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative Prediction of Node-Negative Disease After Neoadjuvant Chemotherapy in Patients Presenting with Node-Negative or Node-Positive Breast Cancer.
    Murphy BL; L Hoskin T; Heins CDN; Habermann EB; Boughey JC
    Ann Surg Oncol; 2017 Sep; 24(9):2518-2525. PubMed ID: 28484921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting axillary sentinel node status in patients with primary breast cancer.
    Kolarik D; Pecha V; Skovajsova M; Zahumensky J; Trnkova M; Petruzelka L; Halaska M; Sottner O; Otcenasek M; Kolarova H
    Neoplasma; 2013; 60(3):334-42. PubMed ID: 23374005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of axillary lymph node metastases in women with early breast cancer in Singapore.
    Tan LG; Tan YY; Heng D; Chan MY
    Singapore Med J; 2005 Dec; 46(12):693-7. PubMed ID: 16308642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probability of axillary lymph node metastasis when sentinel lymph node biopsy is negative in women with clinically node negative breast cancer: a Bayesian approach.
    Okamoto T; Yamazaki K; Kanbe M; Kodama H; Omi Y; Kawamata A; Suzuki R; Igari Y; Tanaka R; Iihara M; Ito Y; Sawada T; Nishikawa T; Maki M; Kusakabe K; Mitsuhashi N; Obara T
    Breast Cancer; 2005; 12(3):203-10. PubMed ID: 16110290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic features predicting involvement of non- sentinel axillary lymph nodes in Iranian women with breast cancer.
    Moosavi SA; Abdirad A; Omranipour R; Hadji M; Razavi AE; Najafi M
    Asian Pac J Cancer Prev; 2014; 15(17):7049-54. PubMed ID: 25227789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Australian-based nomogram predicting nodal positivity for breast cancer in older patients.
    Ofri A; Bhimani N; Warrier S
    Surgeon; 2023 Dec; 21(6):e316-e322. PubMed ID: 37419764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants for non-sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 602 consecutive patients with sentinel node metastases.
    Majid S; Rydén L; Manjer J
    BMC Cancer; 2019 Jun; 19(1):626. PubMed ID: 31238899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axillary nodal metastases in Italian early breast cancer patients with positive sentinel lymph node: can axillary node dissection be avoided by using predictive nomograms?
    Biolchini F; Vicentini M; Di Felice E; Giovanardi F; Antonio L; Giorgi Rossi P; Annessi V
    Tumori; 2015; 101(3):298-305. PubMed ID: 25838248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer.
    Meretoja TJ; Leidenius MH; Heikkilä PS; Boross G; Sejben I; Regitnig P; Luschin-Ebengreuth G; Žgajnar J; Perhavec A; Gazic B; Lázár G; Takács T; Vörös A; Saidan ZA; Nadeem RM; Castellano I; Sapino A; Bianchi S; Vezzosi V; Barranger E; Lousquy R; Arisio R; Foschini MP; Imoto S; Kamma H; Tvedskov TF; Kroman N; Jensen MB; Audisio RA; Cserni G
    J Natl Cancer Inst; 2012 Dec; 104(24):1888-96. PubMed ID: 23117131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.
    Diego EJ; McAuliffe PF; Soran A; McGuire KP; Johnson RR; Bonaventura M; Ahrendt GM
    Ann Surg Oncol; 2016 May; 23(5):1549-53. PubMed ID: 26727919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative).
    Ollila DW; Cirrincione CT; Berry DA; Carey LA; Sikov WM; Hudis CA; Winer EP; Golshan M
    J Am Coll Surg; 2017 Apr; 224(4):688-694. PubMed ID: 28089784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of four published risk models to predict sentinel lymph-node involvement in Australian women with early breast cancer.
    Elmadahm A; Lord SJ; Hudson HM; Lee CK; Buizen L; Farshid G; Gebski VJ; Gill PG
    Breast; 2018 Oct; 41():82-88. PubMed ID: 30007272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.